Announcements Trials
Browse Landscape

Phase

Phase 2 42Phase 3 24Phase NA 13Phase 1 6Phase EARLY_PHASE1 2Phase 2/3 2Phase 1/2 2Phase 4 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Stomach Neoplasms 2Peritoneal Neoplasms 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT05300945 2022-12-06

HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy

Tongji Hospital

Phase 2/3 Not yet recruiting
200 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01683864 2018-01-30

HIPECStomach

University Hospital Tuebingen

Phase 2/3 Terminated
3 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡